Accenture (ACN) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
Some insider buying ($3.2M), but sales were much larger ($15.1M) over the same 12 months.
Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.- 90-day result for Paula A. Price's $200K buy: in on Jan 26, 2027. 1 more buy pending. See the 7- and 30-day results ↓
- Next earnings expected around Dec 31, 2026 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Sale Atsushi Egawa, CEO sold 10,000 shares at $270.00 ($2.7M).
- Trade date
- Nov 5, 2026
- Disclosed to the SEC
- Nov 5, 2026
- Type
- Pre-planned sale, 10b5-1 (code S)
Read the original SEC filing ↗All ACN insider trades ↓
✦ Read the full investigation of Julie Spellman Sweet's $3.0M buy (Oct 28) →
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
ACN insider transactions (Form 4)
Open-market purchases and sales. 336 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Nov 5SEC | Atsushi EgawaCEO | Sell Plan | 10,0005,996 held (−63%) | $270.00 | $2.7M | -16.8% | — |
| Oct 28SEC | Julie Spellman SweetCEO, ChairFirst buy | Buy | 10,10048,910 held (+26%) | $246.17 | $2.5M | -8.8% | — |
| Oct 28SEC | Julie Spellman SweetCEO, ChairFirst buy | Buy | 2,10038,810 held (+6%) | $245.11 | $515K | -8.4% | — |
| Oct 28SEC | Paula A. PriceDirectorFirst buy | Buy | 8009,361 held (+9%) | $249.81 | $200K | -10.1% | — |
| Oct 22SEC | Ryoji SekidoCEO | Sell | 4,7422,296 held (−67%) | $244.73 | $1.2M | -8.2% | — |
| Oct 22SEC | Ryoji SekidoCEO | Sell | 1,1021,194 held (−48%) | $245.28 | $270K | -8.4% | — |
| Oct 22SEC | Melissa A. BurgumChief Accounting Officer | Sell Plan | 8119,820 held (−8%) | $250.00 | $203K | -10.2% | — |
| Oct 13SEC | Catherine Kiernan HoganCOO | Sell Plan | 24212,094 held (−2%) | $214.14 | $52K | +4.9% | — |
| Oct 13SEC | Catherine Kiernan HoganCOO | Sell Plan | 21912,336 held (−2%) | $213.21 | $47K | +5.3% | — |
| Oct 13SEC | Catherine Kiernan HoganCOO | Sell Plan | 20611,888 held (−2%) | $215.13 | $44K | +4.4% | — |
| Oct 13SEC | Catherine Kiernan HoganCOO | Sell Plan | 3211,856 held (−0%) | $216.36 | $7K | +3.8% | — |
| Oct 13SEC | Catherine Kiernan HoganCOO | Sell Plan | 112,555 held (−0%) | $210.80 | $211 | +6.5% | — |
| Oct 9SEC | Catherine Kiernan HoganCOO | Sell Plan | 1,32012,556 held (−10%) | $200.00 | $264K | +12.3% | — |
| Aug 17SEC | Katherine Lee CliffordChief Leadership & Hr Officer | Sell | 68 | $175.97 | $12K | +27.6% | — |
| Jul 31SEC | Joel UnruchGeneral Counsel | Sell Plan | 3,55523,305 held (−13%) | $162.29 | $577K | +38.4% | — |
| Jul 31SEC | Joel UnruchGeneral Counsel | Sell Plan | 2,77217,964 held (−13%) | $164.44 | $456K | +36.6% | — |
| Jul 31SEC | Joel UnruchGeneral Counsel | Sell Plan | 2,56920,736 held (−11%) | $163.27 | $419K | +37.5% | — |
| Jul 31SEC | Joel UnruchGeneral Counsel | Sell Plan | 1,37326,860 held (−5%) | $160.86 | $221K | +39.6% | — |
| Jul 31SEC | Joel UnruchGeneral Counsel | Sell Plan | 22917,735 held (−1%) | $165.16 | $38K | +36.0% | — |
| Apr 30SEC | Atsushi EgawaCEO | Sell Plan | 2,76113,063 held (−17%) | $177.62 | $490K | +26.4% | — |
| Apr 30SEC | Atsushi EgawaCEO | Sell Plan | 1,30615,824 held (−8%) | $176.93 | $231K | +26.9% | — |
| Apr 30SEC | Atsushi EgawaCEO | Sell Plan | 54417,130 held (−3%) | $174.53 | $95K | +28.7% | — |
| Apr 30SEC | Atsushi EgawaCEO | Sell Plan | 26112,802 held (−2%) | $178.58 | $47K | +25.8% | — |
| Feb 10SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 2,25116,278 held (−12%) | $241.77 | $544K | -7.1% | — |
| Feb 10SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 1,84318,529 held (−9%) | $240.90 | $444K | -6.8% | — |
| Feb 10SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 1,02315,255 held (−6%) | $243.15 | $249K | -7.6% | — |
| Feb 10SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 43520,372 held (−2%) | $239.72 | $104K | -6.3% | — |
| Feb 10SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 28820,807 held (−1%) | $238.39 | $69K | -5.8% | — |
| Feb 10SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 21721,095 held (−1%) | $236.11 | $51K | -4.9% | — |
| Feb 5SEC | John F. WalshCEO | Sell Plan | 524,979 held (−0%) | $242.19 | $1K | -7.3% | — |
| Feb 5SEC | John F. WalshCEO | Sell Plan | 424,975 held (−0%) | $243.16 | $973 | -7.6% | — |
| Feb 5SEC | John F. WalshCEO | Sell Plan | 324,972 held (−0%) | $244.48 | $733 | -8.1% | — |
| Feb 5SEC | John F. WalshCEO | Sell Plan | 224,984 held (−0%) | $235.76 | $472 | -4.7% | — |
| Feb 4SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 1,40722,662 held (−6%) | $242.41 | $341K | -7.4% | — |
| Feb 4SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 1,04625,604 held (−4%) | $238.93 | $250K | -6.0% | — |
| Feb 4SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 89224,712 held (−3%) | $240.04 | $214K | -6.4% | — |
| Feb 4SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 64324,069 held (−3%) | $240.62 | $155K | -6.7% | — |
| Feb 4SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 40321,281 held (−2%) | $248.70 | $100K | -9.7% | — |
| Feb 4SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 38421,684 held (−2%) | $246.98 | $95K | -9.1% | — |
| Feb 4SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 36222,300 held (−2%) | $244.50 | $89K | -8.1% | — |
| Feb 4SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 23222,068 held (−1%) | $245.75 | $57K | -8.6% | — |
| Feb 4SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 13121,150 held (−1%) | $249.75 | $33K | -10.1% | — |
| Feb 4SEC | Manish SharmaChief Strategy & Services Ofcr | Sell Plan | 985,031 held (−2%) | $250.36 | $25K | -10.3% | — |
| Feb 4SEC | Melissa A. BurgumChief Accounting Officer | Sell Plan | 158,033 held (−0%) | $250.43 | $4K | -10.3% | — |
| Jan 27SEC | John F. WalshCEO | Sell Plan | 2,60028,083 held (−8%) | $276.15 | $718K | -18.7% | — |
| Jan 27SEC | Melissa A. BurgumChief Accounting Officer | Sell Plan | 2,1618,381 held (−20%) | $281.76 | $609K | -20.3% | — |
| Jan 27SEC | Katherine Lee CliffordChief Leadership & Hr Officer | Sell Plan | 5146,003 held (−8%) | $281.78 | $145K | -20.3% | — |
| Jan 27SEC | John F. WalshCEO | Sell Plan | 52430,683 held (−2%) | $275.28 | $144K | -18.4% | — |
| Jan 27SEC | Melissa A. BurgumChief Accounting Officer | Sell Plan | 50010,870 held (−4%) | $279.64 | $140K | -19.7% | — |
| Jan 27SEC | John F. WalshCEO | Sell Plan | 42927,654 held (−2%) | $277.25 | $119K | -19.0% | — |
| Jan 27SEC | John F. WalshCEO | Sell Plan | 42127,233 held (−2%) | $278.16 | $117K | -19.3% | — |
| Jan 27SEC | Melissa A. BurgumChief Accounting Officer | Sell Plan | 39711,370 held (−3%) | $278.34 | $111K | -19.3% | — |
| Jan 27SEC | Melissa A. BurgumChief Accounting Officer | Sell Plan | 32810,542 held (−3%) | $280.59 | $92K | -20.0% | — |
| Jan 27SEC | Catherine Kiernan HoganCOO | Sell Plan | 26312,916 held (−2%) | $281.27 | $74K | -20.2% | — |
| Jan 27SEC | Catherine Kiernan HoganCOO | Sell Plan | 22712,689 held (−2%) | $282.01 | $64K | -20.4% | — |
| Jan 27SEC | Melissa A. BurgumChief Accounting Officer | Sell Plan | 2028,179 held (−2%) | $282.38 | $57K | -20.5% | — |
| Jan 27SEC | Katherine Lee CliffordChief Leadership & Hr Officer | Sell Plan | 1686,517 held (−3%) | $280.00 | $47K | -19.8% | — |
| Jan 27SEC | Catherine Kiernan HoganCOO | Sell Plan | 10713,179 held (−1%) | $279.63 | $30K | -19.7% | — |
| Jan 27SEC | Katherine Lee CliffordChief Leadership & Hr Officer | Sell Plan | 716,717 held (−1%) | $276.62 | $20K | -18.8% | — |
| Jan 27SEC | Catherine Kiernan HoganCOO | Sell Plan | 6213,286 held (−0%) | $277.76 | $17K | -19.1% | — |
| Jan 27SEC | Katherine Lee CliffordChief Leadership & Hr Officer | Sell Plan | 326,685 held (−0%) | $278.24 | $9K | -19.3% | — |
| Jan 27SEC | John F. WalshCEO | Sell Plan | 1227,221 held (−0%) | $280.00 | $3K | -19.8% | — |
| Jan 27SEC | Katherine Lee CliffordChief Leadership & Hr Officer | Sell Plan | 26,001 held (−0%) | $283.25 | $566 | -20.7% | — |
| Jan 27SEC | Catherine Kiernan HoganCOO | Sell Plan | 112,688 held (−0%) | $283.25 | $283 | -20.7% | — |
| Jan 26SEC | Joel UnruchGeneral Counsel | Sell Plan | 61027,459 held (−2%) | $281.57 | $172K | -20.2% | — |
| Jan 26SEC | Joel UnruchGeneral Counsel | Sell Plan | 21427,245 held (−1%) | $282.44 | $60K | -20.5% | — |
| Jan 26SEC | Joel UnruchGeneral Counsel | Sell Plan | 13828,069 held (−0%) | $280.22 | $39K | -19.9% | — |
| Jan 26SEC | Joel UnruchGeneral Counsel | Sell Plan | 6427,181 held (−0%) | $283.69 | $18K | -20.8% | — |
| Jan 21SEC | Katherine Lee CliffordChief Leadership & Hr Officer | Sell Plan | 1747,041 held (−2%) | $281.38 | $49K | -20.2% | — |
| Jan 21SEC | Katherine Lee CliffordChief Leadership & Hr Officer | Sell Plan | 1296,912 held (−2%) | $282.60 | $36K | -20.5% | — |
| Jan 21SEC | Katherine Lee CliffordChief Leadership & Hr Officer | Sell Plan | 1187,323 held (−2%) | $276.84 | $33K | -18.9% | — |
| Jan 21SEC | Katherine Lee CliffordChief Leadership & Hr Officer | Sell Plan | 646,788 held (−1%) | $284.84 | $18K | -21.2% | — |
| Jan 21SEC | Katherine Lee CliffordChief Leadership & Hr Officer | Sell Plan | 647,259 held (−1%) | $278.38 | $18K | -19.3% | — |
| Jan 21SEC | Katherine Lee CliffordChief Leadership & Hr Officer | Sell Plan | 606,852 held (−1%) | $283.40 | $17K | -20.8% | — |
| Jan 21SEC | Katherine Lee CliffordChief Leadership & Hr Officer | Sell Plan | 447,215 held (−1%) | $279.52 | $12K | -19.7% | — |
| Jan 21SEC | Katherine Lee CliffordChief Leadership & Hr Officer | Sell Plan | 287,441 held (−0%) | $274.19 | $8K | -18.1% | — |
| Jan 15SEC | Manish SharmaChief Strategy & Services Ofcr | Sell Plan | 1,1617,101 held (−14%) | $289.54 | $336K | -22.4% | — |
| Jan 15SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 68737,564 held (−2%) | $289.31 | $199K | -22.4% | — |
| Jan 15SEC | Manish SharmaChief Strategy & Services Ofcr | Sell Plan | 6178,775 held (−7%) | $287.29 | $177K | -21.8% | — |
| Jan 15SEC | Manish SharmaChief Strategy & Services Ofcr | Sell Plan | 5138,262 held (−6%) | $288.64 | $148K | -22.2% | — |
| Jan 15SEC | Mauro MacchiCEO | Sell Plan | 5007,123 held (−7%) | $280.00 | $140K | -19.8% | — |
| Jan 15SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 32138,251 held (−1%) | $288.09 | $92K | -22.0% | — |
| Jan 15SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 30238,572 held (−1%) | $287.12 | $87K | -21.8% | — |
| Jan 15SEC | Manish SharmaChief Strategy & Services Ofcr | Sell Plan | 2979,392 held (−3%) | $285.51 | $85K | -21.3% | — |
| Jan 15SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 17737,387 held (−0%) | $289.98 | $51K | -22.6% | — |
| Jan 15SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 12038,874 held (−0%) | $285.46 | $34K | -21.3% | — |
| Jan 15SEC | Manish SharmaChief Strategy & Services Ofcr | Sell Plan | 919,689 held (−1%) | $281.40 | $26K | -20.2% | — |
| Jan 15SEC | Manish SharmaChief Strategy & Services Ofcr | Sell Plan | 447,057 held (−1%) | $290.21 | $13K | -22.6% | — |
| Jan 15SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 4137,346 held (−0%) | $290.92 | $12K | -22.8% | — |
| Jan 15SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 4138,994 held (−0%) | $281.57 | $12K | -20.2% | — |
| Jan 15SEC | Manish SharmaChief Strategy & Services Ofcr | Sell Plan | 89,780 held (−0%) | $276.61 | $2K | -18.8% | — |
| Jan 15SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 539,035 held (−0%) | $276.61 | $1K | -18.8% | — |
| Jan 7SEC | Mauro MacchiCEO | Sell Plan | 5007,623 held (−6%) | $280.00 | $140K | -19.8% | — |
| Jan 6SEC | Joel UnruchGeneral Counsel | Sell Plan | 1,33228,207 held (−5%) | $275.00 | $366K | -18.3% | — |
| Nov 6SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 4,6569,843 held (−32%) | $246.42 | $1.1M | -8.9% | — |
| Nov 6SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 1,0798,764 held (−11%) | $247.23 | $267K | -9.2% | — |
| Nov 6SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 1658,599 held (−2%) | $248.82 | $41K | -9.7% | — |
| Nov 6SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 1714,499 held (−0%) | $243.38 | $4K | -7.7% | — |
| Oct 30SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 3,80618,381 held (−17%) | $252.92 | $963K | -11.2% | — |
| Oct 30SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 2,10416,277 held (−11%) | $253.92 | $534K | -11.6% | — |
| Oct 30SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 1,76114,516 held (−11%) | $254.84 | $449K | -11.9% | — |
| Oct 30SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 1,32922,187 held (−6%) | $252.05 | $335K | -10.9% | — |
| Oct 23SEC | Manish SharmaChief Strategy & Services Ofcr | Sell Plan | 6,9021,860 held (−79%) | $250.01 | $1.7M | -10.2% | — |
| Oct 23SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 3,91423,603 held (−14%) | $250.13 | $979K | -10.2% | — |
| Oct 23SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 3,78127,517 held (−12%) | $249.41 | $943K | -10.0% | — |
| Oct 23SEC | Ryoji SekidoCEO | Sell Plan | 1,4841,912 held (−44%) | $249.57 | $370K | -10.0% | — |
| Oct 23SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 1,21831,298 held (−4%) | $248.20 | $302K | -9.5% | — |
| Oct 23SEC | Ryoji SekidoCEO | Sell Plan | 5221,390 held (−27%) | $250.23 | $131K | -10.3% | — |
| Oct 23SEC | Ryoji SekidoCEO | Sell Plan | 4943,396 held (−13%) | $248.37 | $123K | -9.6% | — |
| Oct 23SEC | Julie Spellman SweetCEO, Chair | Sell Plan | 8723,516 held (−0%) | $250.87 | $22K | -10.5% | — |
Play with ACN in the Research Lab
Pre-set to ACN's latest insider buy of $10K or more (Oct 28, 2026: Julie Spellman Sweet, Paula A. Price, $3.2M). Tap to change anything.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
- After ACN's buys7, 30 and 90 days later, losses included
- Find buys like this"CEO or CFO bought over $1M after a rally in the last 12 months"
- Compare ACN vs GRABInsider buying and selling side by side
- ACN's board links7 companies share insiders with ACN
- Setup Odds for ACNEvery past buy like this one as a dot
- Play Insider Call5 real buys a day: guess which beat the market
Share price and insider trades
Accenture insider trading at a glance (Nov 20, 2026): in the past 12 months, 2 insiders bought $3.2M and 10 sold $15.1M of ACN stock on the open market; P/E 18.2 vs. a sector median of 26.8.
Setup Odds: how past setups like this did
ACN's latest insider buying (Oct 28, 2026) matched against every similar buy since 2020.
2 insiders buying incl. CEO or CFO $1M+ stock up over 3 months
9 of 26 past setups like this beat the S&P 500 over the next 90 days (35%), against 46% for all insider buys.
History, not a prediction: what happened next in similar past cases, measured from the day the last filing became public. Not investment advice.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
ACN insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | $3.2M | 3 | $4.7M | 10 |
| Q3 2026 | — | 0 | $1.7M | 6 |
| Q2 2026 | — | 0 | $863K | 4 |
| Q1 2026 | — | 0 | $7.7M | 71 |
| Q4 2025 | — | 0 | $8.3M | 16 |
Valuation, profit and volume
Watchlist score 62/100 · selling pressure moderateSource: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 2 Accenture insiders reported open-market purchases totaling $3.2M, while 10 insiders reported sales totaling $15.1M. 104 of 107 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
ACN earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Oct 1, 2026 | -5.2% | None | +8.5%S&P +0.9% | +30.9% |
| Jun 18, 2026 | -16.2% | None | -20.0%S&P +0.7% | +13.6% |
| Mar 19, 2026 | -7.0% | None | +2.5%S&P -1.7% | -0.3% |
| Dec 18, 2025 | +4.9% | None | -0.5%S&P +1.7% | +5.1% |
| Sep 25, 2025 | -5.1% | None | -0.0%S&P +0.1% | +3.6% |
| Jun 20, 2025 | -2.1% | None | -3.7%S&P +0.8% | -2.6% |
| Mar 20, 2025 | -6.2% | None | -5.9%S&P -0.3% | -7.1% |
| Dec 19, 2024 | -1.4% | None | +5.4%S&P +1.2% | -3.4% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
ACN news sentiment trend
Weekly headline tone (positive minus negative headlines) over 13 weeks. Green dots mark weeks with insider buying.
Tone is scored from headline wording only. It describes the news, not where the stock is going.
ACN short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded ACN
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Thomas H TubervilleSenate | Sold $1,001 - $15,000 | Mar 12, 2024 | Aug 5, 2026 | -38.1% |
| Alan ArmstrongSenate | Bought $1,001 - $15,000 | Mar 27, 2026 | Jul 21, 2026 | +19.0% |
| John BoozmanSenate | Sold $1,001 - $15,000 | May 15, 2026 | Jun 16, 2026 | +34.6% |
| Markwayne MullinSenate | Sold $15,001 - $50,000 | Sep 24, 2025 | Oct 1, 2025 | -4.1% |
ACN stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
- 8-K Investor disclosure
- 8-K Earnings release
What happened after ACN insiders bought
Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.
| Filed | Insider | Bought | 7 days | 30 days | 90 days |
|---|---|---|---|---|---|
| Oct 28, 2026 | Paula A. PriceDirector | $200K | +8.6%+9.3% vs S&P | pending | pending |
| Oct 28, 2026 | Julie Spellman SweetCEO, Chair | $3.0M | +8.6%+9.3% vs S&P | pending | pending |
Insiders at Accenture
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Julie Spellman SweetCEO, Chair | $3.0M | $9.3M | Nov 17, 2026 | — | — |
| Atsushi EgawaCEO | — | $3.6M | Nov 17, 2026 | — | — |
| Manish SharmaStrategy/Reinvention Svcs Ofcr | — | $2.5M | Nov 17, 2026 | — | — |
| Joel UnruchGeneral Counsel | — | $2.4M | Nov 17, 2026 | — | — |
| Ryoji SekidoCEO | — | $2.1M | Nov 17, 2026 | — | — |
| Melissa A. BurgumChief Accounting Officer | — | $1.2M | Nov 17, 2026 | — | — |
| John F. WalshCEO | — | $1.1M | Nov 17, 2026 | — | — |
| Paula A. PriceDirector | $200K | — | Nov 17, 2026 | — | — |
| Catherine Kiernan HoganCOO | — | $599K | Nov 17, 2026 | — | — |
| Katherine Lee CliffordChief Leadership & Hr Officer | — | $424K | Nov 17, 2026 | — | — |
| Mauro MacchiCEO | — | $280K | Nov 17, 2026 | — | — |
| Angie Y. ParkCFO | — | — | Nov 17, 2026 | — | — |
| Arun SarinDirector | — | — | Nov 17, 2026 | — | — |
| Tracey Thomas TravisDirector | — | — | Nov 17, 2026 | — | — |
| Nancy McKinstryDirector | — | — | Nov 17, 2026 | — | — |
| Venkata S. M. RenduchintalaDirector | — | — | Nov 17, 2026 | — | — |
| Alan C. JopeDirector | — | — | Nov 17, 2026 | — | — |
| Martin BrudermuellerDirector | — | — | Nov 17, 2026 | — | — |
| Jennifer NasonDirector | — | — | Nov 17, 2026 | — | — |
| Masahiko UotaniDirector | — | — | Nov 17, 2026 | — | — |
| Jaime ArdilaDirector | — | — | Nov 18, 2025 | — | — |
Board links: companies that share insiders with ACN
Directors and executives who filed Form 4s for ACN and another company in the last 12 months.
- MDLZMondelez International Nancy McKinstry Director here · Director at MDLZ · latest filing Nov 17, 2026Paula A. Price Director here · Director at MDLZ · latest filing Nov 17, 2026
- ABTAbbott Laboratories Nancy McKinstry Director here · Director at ABT · latest filing Nov 17, 2026
- ADPAutomatic Data Processing Nancy McKinstry Director here · Director at ADP · latest filing Nov 17, 2026
- FSLRFirst Solar Venkata S. M. Renduchintala Director here · Director at FSLR · latest filing Nov 17, 2026
- METAMeta Platforms Tracey Thomas Travis Director here · Director at META · latest filing Nov 17, 2026
- SCHWCharles Schwab Arun Sarin Director here · Director at SCHW · latest filing Nov 17, 2026
- WBDWarner Bros. Discovery Paula A. Price Director here · Director at WBD · latest filing Nov 17, 2026
Insider activity at other Information Technology companies
Same sector, ranked by insider buying in the last 90 days.
ACN stock: common questions
Are Accenture insiders buying ACN stock?
In the past 12 months, 2 insiders reported open-market purchases of ACN worth $3.2M. The latest was CEO, Chair Julie Spellman Sweet bought $2.5M of ACN at $246.17 — largest purchase by this insider in our records; raises the stake by 26%.
Are Accenture insiders selling ACN stock?
10 insiders reported sales worth $15.1M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is ACN's P/E ratio?
ACN trades at about 18.2 times trailing earnings, compared with a median of 26.8 for the Information Technology sector.
What is ACN's 52-week range?
Over the past year ACN has traded between $122.96 and $282.71. It last closed at $224.57 on Nov 20, 2026.